BrainSight.AI is an AI-powered SaaS tool that helps psychiatrists to diagnose mental disorders using just MRI scans.
Neuro-psychiatric disorders are the leading cause of disability worldwide and cost $650B a year. Yet, most patients never receive an accurate, timely diagnosis at the first instance, because symptom-based psychiatry is ineffective in 70% of cases.
BrainSight.AI’s SaaS offering empowers hospitals to diagnose patients accurately and speedily. Our unique tool provides AI based imaging biomarkers to identify and classify disorders, such as Schizophrenia, Bipolar Disorder and Dementia.
We are pilot testing our prototype with 2 hospital chains, including the largest private hospital chain in India.
Rimjhim Agrawal is finishing her PhD in AI in psychiatry at the prestigious National Institute of Mental Health and Neurosciences, where she developed the
foundational concepts and algorithms that power BrainSight.AI. She has 8 publications and 1 patent in diagnostic systems for complex disorders.
Laina Emmanuel brings the marketplace knowledge and experience. She has worked with high-impact policy-making organizations such as Clinton Health Access Initiative, high-technology firms such as Netapp and has a degree in healthcare business
from the Indian School of Business.